Isomorphic signs up Lilly, Novartis for $3bn AI drug hunt
pharmaphorum
JANUARY 8, 2024
Alphabet’s AI in drug discovery startup Isomorphic Labs signs collaborations with Eli Lilly and Novartis worth up to $3bn, its first two pharma partnerships
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
pharmaphorum
JANUARY 8, 2024
Alphabet’s AI in drug discovery startup Isomorphic Labs signs collaborations with Eli Lilly and Novartis worth up to $3bn, its first two pharma partnerships
Pharmaceutical Technology
JANUARY 23, 2024
Genentech will utilise GenEdit’s non-viral polymer nanoparticles for gene therapy delivery in autoimmune diseases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 17, 2023
Owkin signs up another pharma partner for its AI platform Phil.Taylor Tue, 17/10/2023 - 10:29 Bookmark this
Pharmaceutical Technology
APRIL 6, 2023
US-based biotechnology company ImmunoGen has signed a term loan financing facility worth up to $175m with the entities of Pharmakon Advisors. ImmunoGen will use the proceeds from the agreement to support its growth trajectory and bolster its balance sheet. The company will receive the loan facility in two tranches.
Pharmaceutical Technology
AUGUST 25, 2022
Sonoma Biotherapeutics has signed a lease agreement for setting up an 83,000ft² research and development (R&D) and manufacturing centre for cell therapies. The post Sonoma signs deal to set up manufacturing centre for cell therapies appeared first on Pharmaceutical Technology.
Drug Patent Watch
NOVEMBER 10, 2020
The post Thinking of signing your company up for DrugPatentWatch? We prefer simple flat-rate unrestricted subscriptions — we’ll work on your terms, and with your favorite subscription contract template, to find a solution that fits. If your colleagues would like to…. appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
NOVEMBER 16, 2021
The online retail giant first started offering the telemedicine service to some of its own employees in 2019, setting it up in collaboration with Oasis Medical Group, but in March this year announced its intention to offer it to all US employees as well as other companies. million employees, but brought that to a close earlier this year.
Pharmaceutical Technology
OCTOBER 20, 2023
Daiichi Sankyo will receive an upfront payment of $4bn and will be eligible for additional milestone payments of up to $22bn.
NPR Health - Shots
JANUARY 13, 2023
Nearly 16 million people have already signed up for health insurance through the Affordable Care Act. There are still three more days to sign up. Story aired on ATC on Jan. 12, 2023.)
AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 30, 2022
We spend a third of our lives asleep. And a quarter of our time asleep is spent dreaming. So, for the average person alive in 2022, with a life expectancy of around 73, that clocks in at just over six years of dreaming. Yet, given the central role that dreaming plays in our lives, we […].
Fierce Pharma
JANUARY 10, 2023
Celltrion signs up to support Rani’s oral biosimilar copy of J&J’s Stelara, lands right of first negotiation. Tue, 01/10/2023 - 10:24.
NPR Health - Shots
JANUARY 12, 2023
Nearly 16 million people have enrolled so far, and people can still sign up in most places until Sunday.
Fierce Pharma
SEPTEMBER 11, 2023
After plotting a course to grow by leveraging its biosimilar expertise, Sandoz has inked a deal to get involved in one of the industry's next major biosim debuts. | The blockbuster inflammatory med's patents begin to expire this year, leaving biosimilar makers scrambling for a piece of the large market.
Bio Pharma Dive
SEPTEMBER 29, 2021
Early study results offer some hopeful signs of efficacy, but the small number of patients treated and short follow-up limit firmer conclusions.
Triage Cancer
SEPTEMBER 3, 2020
Have you thought about signing up for an individual plan through the Marketplace? Under FEMA SEP, you can sign up for a Marketplace plan, if: You live in an area during a FEMA-declared disaster or emergency (right now, all US states are covered under the COVID-19 pandemic national emergency declaration).
Trialfacts
MARCH 9, 2023
Participants will be compensated up to $519 for participating in this study. Should participants wake up from a bad dream, they will be asked to push an event-marker button on the wrist actigraph. Sign Up Today! The knowledge gained from this study may help patients get more refined care. Why Participate?
NPR Health - Shots
APRIL 11, 2023
Paying taxes can be agonizing. So can shopping for health insurance. But a handful of states have made enrolling in subsidized or free coverage a little easier for people when they file their taxes (Image credit: d3sign/Getty Images)
Bio Pharma Dive
MARCH 14, 2022
Positive signs for the experimental treatment could help shore up investor confidence in BridgeBio after the December study failure of a drug for a rare heart condition.
BioTech 365
MAY 8, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Daiichi Sankyo, AstraZeneca’s $5B Enhertu follow-up shows early signs of success in breast cancer.Daiichi Sankyo, AstraZeneca’s $5B Enhertu follow-up shows early signs of success in breast cancer … Continue reading (..)
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 5, 2023
The suspected health harms of artificial sweeteners are piling up – and now a new study has linked one kind of sugar substitute to higher risks of heart health problems.
Fierce Pharma
APRIL 25, 2024
Even as new Sanofi drugs like Beyfortus and Altuviiio come into their own, the French pharma’s immunology powerhouse Dupixent shows no signs of slowing down. Even as new Sanofi drugs like Beyfortus and Altuviiio come into their own, the French pharma’s immunology powerhouse Dupixent shows no signs of slowing down.
BioTech 365
DECEMBER 7, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After boosting gene therapy focus, Bayer signs up to new cell therapy pact with Atara.After boosting gene therapy focus, Bayer signs up to new cell therapy pact … Continue reading →
BioTech 365
SEPTEMBER 29, 2021
GlucoModicum and Phillips-Medisize sign a design and development program for the rapid scale-up of its needle-free continuous glucose monitor GlucoModicum and Phillips-Medisize sign a design and development program for the rapid scale-up of its needle-free continuous glucose monitor PRESS RELEASE … Continue reading →
The Pharma Data
AUGUST 20, 2020
Ninety-two staff at Kettering General Hospital in Northamptonshire have signed up to help. “We will then be able to scale-up the use of dogs at ports of entry to identify travellers entering the country with the virus,” he said. Image copyright. MDD/Neil Pollock. Image caption.
STAT News
OCTOBER 17, 2022
Before the Covid-19 pandemic emerged, influenza trackers would begin reading tea leaves around this time of the year, looking for signs of whether there would be an early start to the flu season in the northern hemisphere and which of the various flu viruses might be responsible for the most cases over the coming winter.
BioPharma Reporter
APRIL 22, 2024
SK pharmteco has signed an agreement with Ferring Pharmaceuticals, to scale up commercial manufacturing capacity for the drug substance of Ferringâs intravesical gene therapy Adstiladrin.
Pharmaceutical Technology
NOVEMBER 28, 2022
C4X Discovery (C4XD) and AstraZeneca have entered an exclusive global licensing agreement worth up to $402m to develop oral therapy to treat inflammatory and respiratory ailments. The deal has been signed to develop the C4X NRF2 Activator programme for these ailments. This includes an upfront payment of $2m from AstraZeneca.
pharmaphorum
FEBRUARY 27, 2024
Novo Nordisk has signed a wide-ranging deal with US molecular glue biotech Neomorph that could be worth up to $1.46
Drug Channels
APRIL 26, 2024
To keep up with CoverMyMeds and all the action at Asembia, click here to sign up for daily recaps from Asembia. Click here to learn more about CoverMyMeds’ comprehensive technology solutions. Meet CoverMyMeds in Booth 1305 at the Asembia AXS24 Summit. Read on for Kevin’s insights.
BioTech 365
SEPTEMBER 22, 2020
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine Agreements relate to vaccine candidate using Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant Both companies are committed to … Continue reading →
NPR Health - Shots
SEPTEMBER 5, 2022
The CDC is urging anyone who is eligible to sign up but some vaccine experts say some people might want to wait. Updated COVID boosters are now available for anyone age 12 or older. Image credit: Rogelio V. Solis/AP)
Pharmaceutical Technology
DECEMBER 19, 2022
Innate is also eligible to receive a total of up to $1.43bn (€1.35bn) in preclinical, clinical, regulatory and commercial milestone payments and royalty payments on net sales in the future. As per the deal, Sanofi will hold an option to include up to two further ANKET targets.
NPR Health - Shots
JANUARY 13, 2023
It's the last weekend for Obamacare open enrollment, and nearly 16 million Americans have signed up for a health insurance plan. Image credit: Subin Yang)
BioPharma Reporter
SEPTEMBER 22, 2020
A project run by Gavi, the vaccine alliance, and the World Health Organization (WHO) to guarantee fair access to COVID-19 vaccines worldwide has secured the backing of 64 higher income economies, with a further 38 economies expected to sign in the coming days.
Pharmaceutical Technology
MAY 11, 2023
Half of these patients experienced a rise in neoantigen-specific T cells which persisted for up to two years. At an 18-month follow-up, those who received the treatment were reported to have a longer recurrence-free survival, and the authors concluded that the T cell responses correlated with delayed disease recurrence.
BioPharma Reporter
OCTOBER 9, 2020
China has joined the global effort called COVAX to ensure equitable global access to COVID-19 vaccines.
Pharmaceutical Technology
FEBRUARY 14, 2023
Cullinan Oncology has signed an exclusive licence with Harbour BioMed for clinical-stage B7H4 x 4-1BB bispecific immune activator HBM7008’s (CLN-418) development and marketing in the US. The post Cullinan Oncology signs licence deal with Harbour BioMed appeared first on Pharmaceutical Technology.
NPR Health - Shots
JANUARY 9, 2023
Jeff King had signed up for an alternative that left members of the plan to share the costs of health care. Instead of health insurance, the Rev. That meant lower premiums, but a huge hospital bill. Image credit: Bram Sable-Smith/KHN)
Pharma Mirror
SEPTEMBER 19, 2021
With this agreement, HTL will exclusively develop, scale-up, and supply a high-grade functional injectable Hyaluronic Acid based active ingredient, Sodium Hyaluronate Lipoate Formate (SHLF), for a major part of BMG Pharma’s products.
STAT News
APRIL 4, 2023
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Meet the street medicine team using tech to build trust with unhoused patients Read the rest…
STAT News
SEPTEMBER 23, 2022
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. New details about the Signify bidding war Read the rest…
STAT News
APRIL 25, 2023
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Telehealth providers stay nimble amid regulatory uncertainty Read the rest…
STAT News
APRIL 20, 2023
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Researchers test Microsoft and Epic’s AI Read the rest…
STAT News
APRIL 27, 2023
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. An unvarnished look at health care’s AI reality Read the rest…
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content